refractory MCL

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . relapsed refractory AML . hormone refractory prostate cancer . refractory anemia . rituximab refractory follicular . refractory rituximab naive / m Cl . MCLs . MCLS . McL . MCLD . mcL : MCL medial collateral ligament . torn ACL MCL . ACL MCL . MCL Cafeteria . cell lymphoma MCL . partially torn MCL * *

Related by context. Frequent words. (Click for all words.) 57 refractory multiple myeloma 52 mg BID 52 vandetanib 51 dose escalation 51 metastatic renal cell carcinoma 51 relapsed 51 Torisel 50 IMGN# 50 evaluable patients 49 dose escalation trial 49 HGS ETR1 49 advanced NSCLC 49 randomized #:# 49 mg/m2 49 fludarabine 49 sunitinib 49 dasatinib 48 docetaxel 48 ofatumumab 48 unresectable 48 fluorouracil 48 B CLL 48 HRPC 48 adalimumab 48 Genasense 47 monotherapy 47 Phase IIa trial 47 abatacept 47 pemetrexed 47 Phase Ib 47 median PFS 47 eculizumab 46 J Clin Oncol 46 myelodysplastic syndromes MDS 46 Phase IIa clinical 46 Phase 2b study 46 hepatocellular carcinoma HCC 46 VIDAZA 46 TREANDA 46 cutaneous T cell 46 plus ribavirin 46 Pixantrone 46 melphalan 46 mitoxantrone 46 Phase 1b 46 FOLFOX 46 dose regimen 46 metastatic pancreatic cancer 46 Clolar 46 Phase 2a trial 45 cytarabine 45 peginterferon 45 FOLOTYN 45 Phase 2a clinical 45 relapsing remitting multiple sclerosis 45 AP# [003] 45 RG# [001] 45 chronic myeloid leukemia CML 45 bortezomib 45 lupus nephritis 45 pegylated interferon 45 NNRTI 45 Phase IIa 45 Ribavirin 45 Phase 2a 44 taxane 44 Xcytrin 44 azathioprine 44 ZEVALIN 44 temozolomide 44 TMC# [001] 44 linezolid 44 Ann Intern Med 44 G CSF 44 NSCLC 44 chronic lymphocytic leukemia CLL 44 VELCADE 44 aripiprazole 44 bevacizumab 44 liver metastases 44 Marqibo 44 tumor regression 44 lenalidomide 44 topotecan 44 resistant ovarian cancer 43 dosing regimens 43 Zevalin 43 HCV genotype 1 43 metastatic colorectal cancer 43 chemoradiation 43 DMARDs 43 myelofibrosis 43 irinotecan 43 febrile neutropenia 43 oxaliplatin 43 sorafenib 43 mCRC 43 Phase 2b clinical 43 clofarabine 43 lamivudine 43 capecitabine

Back to home page